FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167372101> ?p ?o ?g. }

• W3167372101 abstract "Access to essential medicines and vaccines remains an uphill battle for approximately eighty percent of the two billion people living in low- and middle-income countries today. Despite significant efforts to shoulder the burden by the international community, the challenges of funding medicines continue to expand in light of growing disease burden and ever-increasing prices for both infectious diseases and non-communicable diseases across countries. ‘Tiered pricing’ or the option of offering drugs and vaccines at lower (and more affordable) prices in low- and middle-income countries when compared to high income countries has been proposed as a potential solution to this problem. Given the recurring and extreme relevance of this topic, this article sets out by providing a theoretical and empirical account on inter-country tiered pricing strategies by tracing the developments in HIV/AIDS, Hepatitis C and Cancer categories as the main points of reference. Section II reviews the welfare effects of inter-country tiered pricing to show how it is based on third-degree price discrimination; a pricing method that remains the most disputed form of differentiation in economic theory. It highlights the reasons – both market-related, and institution- related – that account for the difficulties in aligning incentives between firms and governments to promote access to medicines by way of this approach. The section then presents thorough empirical evidence on tiered pricing in the three chosen therapeutic categories to highlight how inter-country tiered pricing approaches, as currently practiced, can perpetuate socially unequal outcomes, both for competition and access, and narrows down the factors that broadly account for this. Can these incentives potentially be altered by designing legal and institutional frameworks that promote new ways to engage in tiered pricing in a more accountable manner? The rest of the paper addresses this question at length and argues that there are ways to eliminate many of the undesirable outcomes that we witness in inter-country tiered pricing strategies today. One way would be to offer different price categories within a given country, namely, through an intra-country pricing strategy (as opposed to the current practice of tier-pricing between countries) within an accountable regulatory framework that oversees and coordinates pricing practices. The final part of the paper outlines the preliminary contours of such a framework (both national and international) to implement intra-country tiered pricing strategies that aligns greater access and dynamic competition in a systematic manner. A number of findings derived by the paper – such as the relationship between tiered pricing and competition, and the need for a new global policy framework to oversee pricing - are highly relevant for global governance of the pharmaceutical sector to enhance access to medicines to one and all." @default.
• W3167372101 created "2021-06-22" @default.
• W3167372101 creator A5000817456 @default.
• W3167372101 date "2020-01-01" @default.
• W3167372101 modified "2023-09-23" @default.
• W3167372101 title "A Proposal for New Pricing Approaches to Enhance Access to Medicines" @default.
• W3167372101 doi "https://doi.org/10.2139/ssrn.3656916" @default.
• W3167372101 hasPublicationYear "2020" @default.
• W3167372101 type Work @default.
• W3167372101 sameAs 3167372101 @default.
• W3167372101 citedByCount "0" @default.
• W3167372101 crossrefType "journal-article" @default.
• W3167372101 hasAuthorship W3167372101A5000817456 @default.
• W3167372101 hasConcept C100001284 @default.
• W3167372101 hasConcept C111472728 @default.
• W3167372101 hasConcept C120936955 @default.
• W3167372101 hasConcept C138885662 @default.
• W3167372101 hasConcept C144133560 @default.
• W3167372101 hasConcept C162324750 @default.
• W3167372101 hasConcept C166052673 @default.
• W3167372101 hasConcept C175444787 @default.
• W3167372101 hasConcept C29122968 @default.
• W3167372101 hasConceptScore W3167372101C100001284 @default.
• W3167372101 hasConceptScore W3167372101C111472728 @default.
• W3167372101 hasConceptScore W3167372101C120936955 @default.
• W3167372101 hasConceptScore W3167372101C138885662 @default.
• W3167372101 hasConceptScore W3167372101C144133560 @default.
• W3167372101 hasConceptScore W3167372101C162324750 @default.
• W3167372101 hasConceptScore W3167372101C166052673 @default.
• W3167372101 hasConceptScore W3167372101C175444787 @default.
• W3167372101 hasConceptScore W3167372101C29122968 @default.
• W3167372101 hasLocation W31673721011 @default.
• W3167372101 hasOpenAccess W3167372101 @default.
• W3167372101 hasPrimaryLocation W31673721011 @default.
• W3167372101 hasRelatedWork W10344688 @default.
• W3167372101 hasRelatedWork W11937253 @default.
• W3167372101 hasRelatedWork W13019631 @default.
• W3167372101 hasRelatedWork W13409808 @default.
• W3167372101 hasRelatedWork W24807454 @default.
• W3167372101 hasRelatedWork W40348051 @default.
• W3167372101 hasRelatedWork W4862725 @default.
• W3167372101 hasRelatedWork W5666230 @default.
• W3167372101 hasRelatedWork W9053130 @default.
• W3167372101 hasRelatedWork W9532454 @default.
• W3167372101 isParatext "false" @default.
• W3167372101 isRetracted "false" @default.
• W3167372101 magId "3167372101" @default.
• W3167372101 workType "article" @default.